Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3 Business Technology Group Regulatory News (KBT)

  • There is currently no data for KBT

Publication of Circular and Update

3 Apr 2025 07:00

RNS Number : 4377D
K3 Business Technology Group PLC
03 April 2025
 

AIM: KBT

K3 BUSINESS TECHNOLOGY GROUP PLC

("K3" or "the Group" or "the Company")

 

· Publication of Circular relating to

Proposed Share Capital Reduction, Proposed Cancellation of the Share Premium Account

and Notice of General Meeting

 

· Update regarding possible return of value to Shareholders and future plans, including possible de-listing

 

K3, which provides business-critical software solutions focused on fashion and apparel brands, is pleased to announce that following the sale of NexSys Solutions Limited ("NexSys"), completed in January 2025 for a gross cash consideration of £36.0 million, the K3 Board believes that up to approximately £29 million of the net proceeds, which amounted to £34.3 million, can be returned to Shareholders. This is after considering the Group's current cash balances and the Board's expectations of the Group's future cash requirements.

The mechanism of any return of net proceeds would be by way of a Tender Offer and is, inter alia, subject to the completion of a share capital reduction (so as to create the necessary distributable reserves) and approval by Shareholders at a general meeting.

A circular explaining the details of and reasons for the proposed Share Capital Reduction and why the Board considers the Share Capital Reduction to be in the best interests of the Company and its Shareholders as a whole, has been published today and will be sent to Shareholders. The proposed Share Capital Reduction would result in, amongst other things, a reduction in the nominal value of the Existing Ordinary Shares, from 25p to 5p, though the number of shares in issue would not change.

The Circular contains a Notice of General Meeting, convened for 11.00 a.m. on 24 April 2025 at the offices of Cavendish Capital Markets at One Bartholomew Close, London, WC1A 7BL. Part IV of the Circular sets out the Special Resolution, which is being proposed to Shareholders in order to facilitate the Share Capital Reduction. The Share Capital Reduction is also subject to an appropriate Order of His Majesty's High Court of Justice in England. The Directors unanimously recommend that Shareholders vote in favour of the Special Resolution to be proposed at the General Meeting as they intend to do so in respect of their beneficial holdings, which in aggregate amount to 61,701 Existing Ordinary Shares, representing approximately 0.14 per cent. of the Company's existing issued Ordinary Share Capital. Kestrel Partners LLP has given an irrevocable undertaking to vote in favour of the Special Resolution in respect of an aggregate 12,990,869 Existing Ordinary Shares, representing approximately 28.33 per cent. of the Company's existing ordinary share capital.

The expected timetable of principal events is set out below. The Circular will be made available on the Company's corporate website at https://www.k3btg.com/investor-centre/.

Current Trading and Future Prospects

Following the NexSys Sale, the Group's continuing operations comprise:

the K3 Fashion portfolio, with annual recurring revenue ("ARR") of c.£6.0 million at 30 November 2024 (2023: £5.8m);

the K3 Retail Solutions Business, with ARR of £5.8m at 30 November 2024 (2023: £5.8m); and

the K3 Global Accounts services business, with revenue of £10.9m for the year ended 30 November 2024 (2023: £18.6m).

The Board is pleased to reconfirm its expectation set out in K3's Final Results for 30 November 2024, announced on 27 February 2025, that the Group's continuing operations will trade on a cash breakeven basis from March 2025 onwards.

Group pro forma cash balances at 28 February 2025, assuming £29 million of capital is returned to shareholders, would be £6.1 million (including £3.3 million of restricted cash, which is restricted until July 2026).

The Board's focus remains on delivering value to Shareholders. It is expected that this will be achieved by maintaining strong financial discipline, continuing to simplify the Group as appropriate through the sale of non-core businesses and to invest judiciously in profitable growth opportunities. As further cash is realised in the Group, the Board intends to return it to Shareholders in a timely manner.

Future Plans for the Group and Possible De-listing from AIM

Following the NexSys Sale and in line with the Board's ongoing strategy to reduce costs and simplify the Group, the Board and certain Shareholders have raised the question as to whether the Company's and Shareholders' best interests are served by its continued admission to AIM following the planned return of value to Shareholders. Accordingly, the Board will consult further with Shareholders on this subject before recommending any course of action. Where the Board concludes that a de-listing from AIM is the appropriate course of action, a separate general meeting will be convened for a later date in order that Shareholders can consider and vote on a special resolution proposing a de-listing from AIM. Should such a de-listing be agreed, it would be organised to become effective as soon as practicable after the planned return of value to Shareholders. 

Unless otherwise indicated all defined terms in this announcement shall have the same meaning as described in the Circular.

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

Publication of Circular document

3 April 2025

Latest time for receipt of online proxy votes and Forms of Proxy for the General Meeting

11.00 am on 22 April 2025

General Meeting

11.00 am on 24 April 2025

Expected date of initial directions hearing of the Court

21 May 2025

Expected date of Court Hearing to confirm the Share Capital Reduction

10 June 2025

Registration of Court Order and Expected Effective Date for the Share Capital Reduction

by 13 June 2025

Notes

 

The expected dates for the confirmation of the Share Capital Reduction by the Court and the Share Capital reduction becoming effective are based on provisional dates that have been obtained for the required Court hearings of the Company's application. These provisional hearing dates are subject to change and dependent on the Court's timetable. If the expected dates of the Court hearings are changed (and consequently the expected effective date for the Share Capital Reduction), the Company will make further notifications via a Regulatory Information Service.

The timetable assumes that there is no adjournment of the General Meeting. If there is an adjournment, all subsequent dates are likely to be later than those shown.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

Enquiries:

 

K3 Business Technology Group plc

Oliver Scott, Chairman

T: c/o 020 3178 6378

www.k3btg.com

Eric Dodd, Chief Executive Officer

 

 

Cavendish Capital Markets

(NOMAD & Broker)

Julian Blunt/ Dan Hodkinson

(Corporate Finance)

Sunila De Silva

(Corporate Broking)

T: 020 7220 0500

KTZ Communications

Katie Tzouliadis/ Robert Morton

T: 020 3178 6378

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSEEFEEISEEL
Date   Source Headline
30th Jul 20257:00 amRNSCancellation - K3 Business Technology Group Plc
25th Jul 202512:10 pmRNSHolding(s) in Company
21st Jul 202511:14 amRNSResult of Tender Offer
18th Jul 202512:06 pmRNSResult of General Meeting
2nd Jul 20257:00 amRNSProposed Tender Offer, Cancellation & Notice of GM
24th Jun 202512:01 pmRNSCompletion of Capital Reduction
17th Jun 202512:31 pmRNSPDMR Announcement
11th Jun 20251:22 pmRNSUpdate re. Capital Reduction
4th Jun 202511:56 amRNSTotal Voting Rights
3rd Jun 202511:05 amRNSHolding(s) in Company
29th May 20259:01 amRNSPDMR Announcement
23rd May 20255:08 pmRNSTR-1 Notification
22nd May 202512:42 pmRNSExercise of warrants, issue of shares and TVR
19th May 20255:12 pmRNSExercise of warrants, issue of shares and TVR
24th Apr 20254:27 pmRNSResult of General Meeting
24th Apr 20254:22 pmRNSResult of AGM
3rd Apr 20257:01 amRNSBoard Change
3rd Apr 20257:00 amRNSPublication of Circular and Update
27th Feb 20257:00 amRNSFinal Results
19th Dec 20241:00 pmRNSResult of General Meeting
9th Dec 20243:50 pmRNSPDMR Announcement
2nd Dec 20247:00 amRNSProposed disposal of NexSys Solutions Ltd for £36m
30th Sep 20247:00 amRNSDirector/PDMR Shareholding
27th Sep 20247:00 amRNSBoard Change
24th Sep 20242:42 pmRNSHolding(s) in Company
24th Sep 20249:02 amRNSDirector/PDMR Shareholding
2nd Sep 20247:00 amRNSPDMR Announcement
23rd Aug 20245:16 pmRNSPDMR Announcement
17th Jul 20247:00 amRNSChange of Auditor
17th Jul 20247:00 amRNSBoard Appointment
17th Jul 20247:00 amRNSInterim Results
4th Jul 20247:00 amRNSBoard changes
21st May 20245:56 pmRNSResult of AGM
13th May 20249:00 amRNSPDMR Announcement
7th May 20242:29 pmRNSPDMR Announcement
26th Apr 20247:00 amRNSPosting of Annual Report and Notice of AGM
8th Apr 202410:50 amRNSPDMR Announcement
2nd Apr 20244:00 pmRNSPDMR Announcement
26th Mar 20247:00 amRNSFinal Results
29th Jan 20241:00 pmRNSPDMR Announcement
15th Jan 202410:00 amRNSPDMR Announcement
20th Dec 20237:00 amRNSTrading Update
19th Dec 20238:52 amRNSPDMR Announcement
21st Nov 20237:00 amRNSPDMR Announcement
30th Oct 20237:00 amRNSBoard Changes
30th Aug 20237:00 amRNSInterim Results
21st Jul 20235:50 pmRNSPDMR Announcement
7th Jul 20235:10 pmRNSPDMR Announcement
30th Jun 20235:15 pmRNSPDMR Announcement
23rd Jun 20236:00 pmRNSPDMR Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.